NO934721D0 - Hemmere av HIV-protease som er nyttige for behandling av AIDS - Google Patents
Hemmere av HIV-protease som er nyttige for behandling av AIDSInfo
- Publication number
- NO934721D0 NO934721D0 NO934721A NO934721A NO934721D0 NO 934721 D0 NO934721 D0 NO 934721D0 NO 934721 A NO934721 A NO 934721A NO 934721 A NO934721 A NO 934721A NO 934721 D0 NO934721 D0 NO 934721D0
- Authority
- NO
- Norway
- Prior art keywords
- aids
- treatment
- protease inhibitors
- hiv protease
- inhibitors useful
- Prior art date
Links
- 208000030507 AIDS Diseases 0.000 title 1
- 239000004030 hiv protease inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
- C07D215/60—N-oxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99562192A | 1992-12-22 | 1992-12-22 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO934721D0 true NO934721D0 (no) | 1993-12-20 |
| NO934721L NO934721L (no) | 1994-06-23 |
Family
ID=25542022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO934721A NO934721L (no) | 1992-12-22 | 1993-12-20 | Hemmere av HIV-protease som er nyttige for behandling av AIDS |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0609625A1 (no) |
| JP (1) | JPH06256277A (no) |
| KR (1) | KR940014336A (no) |
| CN (1) | CN1092410A (no) |
| AU (1) | AU5252993A (no) |
| BR (1) | BR9305161A (no) |
| CA (1) | CA2112052A1 (no) |
| CO (1) | CO4180513A1 (no) |
| CZ (1) | CZ281393A3 (no) |
| FI (1) | FI935780A7 (no) |
| HU (1) | HUT69703A (no) |
| IL (1) | IL108098A0 (no) |
| MX (1) | MX9308025A (no) |
| NO (1) | NO934721L (no) |
| PL (1) | PL301578A1 (no) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5484926A (en) * | 1993-10-07 | 1996-01-16 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
| US5747540A (en) * | 1996-10-21 | 1998-05-05 | Merck & Co., Inc. | HIV protease inhibitors useful for the treatment of AIDS |
| JP2003528071A (ja) | 2000-03-23 | 2003-09-24 | エラン ファーマスーティカルズ インコーポレイテッド | アルツハイマー病治療用組成物および方法 |
| PE20020276A1 (es) | 2000-06-30 | 2002-04-06 | Elan Pharm Inc | COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER |
| US6846813B2 (en) | 2000-06-30 | 2005-01-25 | Pharmacia & Upjohn Company | Compounds to treat alzheimer's disease |
| EP1666452A2 (en) | 2000-06-30 | 2006-06-07 | Elan Pharmaceuticals, Inc. | Compounds to treat Alzheimer's disease |
| JP2004502665A (ja) | 2000-06-30 | 2004-01-29 | イーラン ファーマスーティカルズ、インコーポレイテッド | アルツハイマー病を治療する化合物 |
| DE60039921D1 (de) * | 2000-09-29 | 2008-09-25 | Neurogen Corp | Hochaffine kleinmolekülige c5a-rezeptor-modulatoren |
| WO2003002122A1 (en) | 2001-06-27 | 2003-01-09 | Elan Pharmaceuticals, Inc. | Beta-hydroxyamine derivatives useful in treatment of alzheimer's disease |
| DK1406898T3 (da) * | 2001-07-19 | 2005-05-30 | Cv Therapeutics Inc | Substituerede piperazinforbindelser og anvendelse af disse som fedtsyreoxidationsinhibitorer |
| US7244755B2 (en) | 2001-10-04 | 2007-07-17 | Pharmacia & Upjohn Company | Hydroxypropylamines |
| WO2004058686A1 (en) | 2002-04-30 | 2004-07-15 | Elan Pharmaceuticals, Inc. | Hydroxypropyl amides for the treatment of alzheimer’s disease |
| JP4698991B2 (ja) * | 2004-09-14 | 2011-06-08 | 日本曹達株式会社 | ピリジルメチルカルバミン酸エステル化合物、その製造方法及びピリジルメチルアミン化合物の製造方法 |
| JP4721214B2 (ja) * | 2004-09-14 | 2011-07-13 | 日本曹達株式会社 | ピリジルメチルカルバミン酸エステル化合物及びピリジルメチルアミン化合物の製造方法 |
| NZ562314A (en) | 2005-04-08 | 2010-02-26 | Comentis Inc | Compounds which inhibit beta-secretase activity and methods of use thereof |
| EP2307345A4 (en) * | 2008-07-01 | 2012-05-02 | Purdue Research Foundation | NON-PEPTIDINHIBITORS OF HIV-1 PROTEASE |
| GB201905721D0 (en) | 2019-04-24 | 2019-06-05 | Univ Dundee | Compounds |
| CN110872251A (zh) * | 2019-11-28 | 2020-03-10 | 卡博金艾美斯医药(上海)有限公司 | N-乙基吡啶甲胺三氟乙酸盐及其晶体、制备工艺和应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0361341A3 (en) * | 1988-09-28 | 1991-07-03 | Miles Inc. | Therapeutics for aids based on inhibitors of hiv protease |
| WO1991008221A1 (en) * | 1989-12-04 | 1991-06-13 | Wisconsin Alumni Research Foundation | Peptide inhibitors of hiv protease |
| GB8927913D0 (en) * | 1989-12-11 | 1990-02-14 | Hoffmann La Roche | Amino acid derivatives |
-
1993
- 1993-12-15 MX MX9308025A patent/MX9308025A/es unknown
- 1993-12-17 CZ CZ932813A patent/CZ281393A3/cs unknown
- 1993-12-20 EP EP93310355A patent/EP0609625A1/en not_active Withdrawn
- 1993-12-20 HU HU9303677A patent/HUT69703A/hu unknown
- 1993-12-20 AU AU52529/93A patent/AU5252993A/en not_active Abandoned
- 1993-12-20 CO CO93423578A patent/CO4180513A1/es unknown
- 1993-12-20 NO NO934721A patent/NO934721L/no unknown
- 1993-12-20 IL IL10809893A patent/IL108098A0/xx unknown
- 1993-12-20 PL PL93301578A patent/PL301578A1/xx unknown
- 1993-12-21 CA CA002112052A patent/CA2112052A1/en not_active Abandoned
- 1993-12-21 JP JP5321876A patent/JPH06256277A/ja not_active Withdrawn
- 1993-12-21 FI FI935780A patent/FI935780A7/fi not_active Application Discontinuation
- 1993-12-21 CN CN93112960A patent/CN1092410A/zh active Pending
- 1993-12-21 BR BR9305161A patent/BR9305161A/pt not_active Application Discontinuation
- 1993-12-22 KR KR1019930029120A patent/KR940014336A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| BR9305161A (pt) | 1994-11-01 |
| PL301578A1 (en) | 1994-06-27 |
| HU9303677D0 (en) | 1994-04-28 |
| CN1092410A (zh) | 1994-09-21 |
| MX9308025A (es) | 1994-08-31 |
| JPH06256277A (ja) | 1994-09-13 |
| AU5252993A (en) | 1994-07-07 |
| NO934721L (no) | 1994-06-23 |
| CZ281393A3 (en) | 1994-07-13 |
| FI935780A0 (fi) | 1993-12-21 |
| HUT69703A (en) | 1995-09-28 |
| IL108098A0 (en) | 1994-04-12 |
| EP0609625A1 (en) | 1994-08-10 |
| FI935780A7 (fi) | 1994-06-23 |
| KR940014336A (ko) | 1994-07-18 |
| CA2112052A1 (en) | 1994-06-23 |
| CO4180513A1 (es) | 1995-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO954427D0 (no) | Hiv-proteaseinhibitorer som er anvendbare for behandling av AIDS | |
| FI935778A7 (fi) | HIV-proteaasin inhibiittoreita, jotka ovat hyödyllisiä AIDSin hoitoa varten | |
| NO893400L (no) | Hiv protease inhibitorer egnet for behandling av aids. | |
| NO905428D0 (no) | Fremgangsmaate for fremstilling av hiv-proteaseinhibitorerfor behandling av aids. | |
| EP0604182A3 (en) | HIV protease inhibiting compounds. | |
| FI981591L (fi) | AIDS:n hoidossa käyttökelpoisia HIV-proteaasi-inhibiittoreita | |
| FI951059A0 (fi) | HIV-aspartyyliproteaasin sulfonamidi-inhibiittoreita | |
| IL102428A0 (en) | Inhibitors of hiv protease useful for the treatment of aids | |
| FI891716A7 (fi) | HIV-proteaasi-inhibiittoreita, jotka ovat käyttökelpoisia AIDS'in hoidossa | |
| NO893834D0 (no) | Terapeutiske forbindelser for aids basert paa hemmere av hiv-protease. | |
| FI954580L (fi) | HIV-proteaasin estäjiä farmaseuttisissa yhdistelmissä käytettäväksi AIDSin hoitoon | |
| ATE222240T1 (de) | Hiv - protease inhibitoren | |
| FI935780A7 (fi) | HIV-proteaasin inhibiittoreita, jotka ovat hyödyllisiä AIDSin hoitoa varten | |
| FI935777L (fi) | AIDSin hoitamisessa käyttökelpoiset HIV-proteaasin inhibiittorit | |
| FI935779A7 (fi) | HIV-proteaasin inhibiittoreita, jotka ovat hyödyllisiä AIDSin hoitoa varten | |
| NO932130D0 (no) | Hemmere av hiv-protease som er nyttige for behandling av aids | |
| NO962000D0 (no) | Prolegemidler av en inhibitor av HIV-protease | |
| ZA925023B (en) | Inhibitors of HIV protease useful for the treatment of AIDS | |
| GB9515802D0 (en) | Hiv protease inhibitors useful for the treatment of aids | |
| NO905003D0 (no) | Fremgangsmaate for fremstilling av proteaseinhibitorer frapotetsaft. | |
| ZA939475B (en) | Inhibitors of HIV protease useful for the treatment of Aids | |
| ZA928563B (en) | HIV protease inhibitors useful for the treatment of AIDS. | |
| AU620084C (en) | HIV protease inhibitors useful for the treatment of aids | |
| ZA896430B (en) | Hiv protease inhibitors useful for the treatment of aids | |
| ZA9010125B (en) | Hiv protease inhibitors useful for the treatment of aids |